Search research articles
Contact Us
Filters
Showing results (211-220 of 225) with videos related to
Page
of 23
Sort By:
BMC Health Services Research
|
June 27, 2023
Patient and clinician perspectives of a remote monitoring program for COVID-19 and lessons for future programs
Krisda H Chaiyachati, Judy A Shea, Michaela Ward, et al.
Biochemical and Biophysical Research Communications
|
July 21, 2024
The TGF-β1 target WISP1 is highly expressed in liver cirrhosis and cirrhotic HCC microenvironment and involved in pro- and anti-tumorigenic effects
Anne Dropmann, Sophie Alex, Katharina Schorn, et al.
The American Journal of Pathology
|
May 13, 2016
Delta-Like Ligand 4 Modulates Liver Damage by Down-Regulating Chemokine Expression
Zhe Shen, Yan Liu, Bedair Dewidar, et al.
Oncotarget
|
May 11, 2017
Apelin: A putative novel predictive biomarker for bevacizumab response in colorectal cancer
Linda Zuurbier, Arman Rahman, Martijn Cordes, et al.
Nature Plants
|
January 2, 2019
Sunflower pan-genome analysis shows that hybridization altered gene content and disease resistance
Sariel Hübner, Natalia Bercovich, Marco Todesco, et al.
Gut
|
March 25, 2017
BMP-9 interferes with liver regeneration and promotes liver fibrosis
Katja Breitkopf-Heinlein, Christoph Meyer, Courtney König, et al.
Scientific Reports
|
June 20, 2020
Combination of variations in inflammation- and endoplasmic reticulum-associated genes as putative biomarker for bevacizumab response in KRAS wild-type colorectal cancer
Ana Barat, Dominiek Smeets, Bruce Moran, et al.
Cell Reports. Medicine
|
August 9, 2025
Combined MEK and PARP inhibition enhances radiation response in rectal cancer
Qiyun Xiao, Julian E Riedesser, Theresa Mulholland, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 10, 2022
Correction to: Severe Dysbiosis and Specific Haemophilus and Neisseria Signatures as Hallmarks of the Oropharyngeal Microbiome in Critically Ill Coronavirus Disease 2019 (COVID-19) Patients
Juliana de Castilhos, Eli Zamir, Theresa Hippchen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 25, 2021
Severe Dysbiosis and Specific Haemophilus and Neisseria Signatures as Hallmarks of the Oropharyngeal Microbiome in Critically Ill Coronavirus Disease 2019 (COVID-19) Patients
Juliana de Castilhos, Eli Zamir, Theresa Hippchen, et al.
Page
of 23
Search research articles
Search
Showing results (211-220 of 225) with videos related to
Sort By:
Page
of 23
BMC Health Services Research
|
June 27, 2023
Patient and clinician perspectives of a remote monitoring program for COVID-19 and lessons for future programs
Krisda H Chaiyachati, Judy A Shea, Michaela Ward, et al.
Biochemical and Biophysical Research Communications
|
July 21, 2024
The TGF-β1 target WISP1 is highly expressed in liver cirrhosis and cirrhotic HCC microenvironment and involved in pro- and anti-tumorigenic effects
Anne Dropmann, Sophie Alex, Katharina Schorn, et al.
The American Journal of Pathology
|
May 13, 2016
Delta-Like Ligand 4 Modulates Liver Damage by Down-Regulating Chemokine Expression
Zhe Shen, Yan Liu, Bedair Dewidar, et al.
Oncotarget
|
May 11, 2017
Apelin: A putative novel predictive biomarker for bevacizumab response in colorectal cancer
Linda Zuurbier, Arman Rahman, Martijn Cordes, et al.
Nature Plants
|
January 2, 2019
Sunflower pan-genome analysis shows that hybridization altered gene content and disease resistance
Sariel Hübner, Natalia Bercovich, Marco Todesco, et al.
Gut
|
March 25, 2017
BMP-9 interferes with liver regeneration and promotes liver fibrosis
Katja Breitkopf-Heinlein, Christoph Meyer, Courtney König, et al.
Scientific Reports
|
June 20, 2020
Combination of variations in inflammation- and endoplasmic reticulum-associated genes as putative biomarker for bevacizumab response in KRAS wild-type colorectal cancer
Ana Barat, Dominiek Smeets, Bruce Moran, et al.
Cell Reports. Medicine
|
August 9, 2025
Combined MEK and PARP inhibition enhances radiation response in rectal cancer
Qiyun Xiao, Julian E Riedesser, Theresa Mulholland, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 10, 2022
Correction to: Severe Dysbiosis and Specific Haemophilus and Neisseria Signatures as Hallmarks of the Oropharyngeal Microbiome in Critically Ill Coronavirus Disease 2019 (COVID-19) Patients
Juliana de Castilhos, Eli Zamir, Theresa Hippchen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 25, 2021
Severe Dysbiosis and Specific Haemophilus and Neisseria Signatures as Hallmarks of the Oropharyngeal Microbiome in Critically Ill Coronavirus Disease 2019 (COVID-19) Patients
Juliana de Castilhos, Eli Zamir, Theresa Hippchen, et al.
Page
of 23